Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection-Reference-Cited by-同舟云学术

Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection

Published:2014 Issue:3 Volume:86 Page:136
ISSN:2288-6575
Container-title:Annals of Surgical Treatment and Research
language:en
Short-container-title:Ann Surg Treat Res

Author:

Kim Kyongchol¹,Shin Dong Gue²,Park Min Koo³,Baik Seung Hyuk⁴,Kim Tae Hee⁵,Kim Sanghee⁶,Lee SaeYoung⁷

Affiliation:

1. The Clinical Genome Center, Chaum Life Center, Cha University, Seoul, Korea.

2. Department of Surgery, Seoul Medical Center, Seoul, Korea.

3. TCM Epigenetics and Genomics Lab, Seoul, Korea.

4. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Medical Oncology, Seoul Metropolitan Dongbu Hospital, Seoul, Korea.

6. College of Nursing, Yonsei University, Seoul, Korea.

7. Department of Family Medicine, Mizmedi Hospital, Seoul, Korea.

Publisher

The Korean Surgical Society

Subject

Surgery

Link

https://synapse.koreamed.org/pdf/10.4174/astr.2014.86.3.136

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications and perspectives of circulating tumor DNA in gastric cancer;Cancer Cell International;2024-01-06

2. Landscape of Innovative Methods for Early Diagnosis of Gastric Cancer: A Systematic Review;Diagnostics;2023-12-05

3. Plasma Cell-Free DNA and Caspase-3 Levels in Patients with Chronic Kidney Disease;Journal of Clinical Medicine;2023-08-28

4. Current and emerging applications of liquid biopsy in pan-cancer;Translational Oncology;2023-08

5. Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives;International Journal of Molecular Sciences;2023-05-29